Pierre Wallemacq - Concepedia

Author

Pierre Wallemacq

Also Known As

H. Shimpuku, Jacques Malaise, Jean-Michel Dogné, P E Wallemacq, P Wallemacq, P. E. Wallemacq, P. Wallemacq, P.E Wallemacq, P.E. Wallemacq, PIERRE WALLEMACQ

351

Publications

10.5K

Citations

H-Index

176

Concepts

All Affiliations

UCLouvain Cliniques Universitaires Saint-Luc KU Leuven Université Libre de Bruxelles

About

Pierre Wallemacq is an author at UCLouvain specializing in medicine, pharmacology, and bioanalysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	78	3.3K
2	Natural Sciences	7	7	151
3	Health Sciences	5	5	150
4	Engineering	4	4	148
5	Public Health	4	4	173

Pierre Wallemacq

162

Publications

Citations

H-Index

Page 1

	Year	Citations
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference Pierre Wallemacq, Victor W. Armstrong, Merçè Brunet, Therapeutic Drug Monitoring Uniform DoseSolid Organ TransplantationTransplantation MedicineSurgeryPharmacotherapy	2009	453
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients Vincent Haufroid, Michel Mourad, Val rie Van Kerckhove, Pharmacogenetics Specific PolymorphismTransplantationKidney TransplantTrough Blood LevelsMedicine	2004	444
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock Fabio Silvio Taccone, Pierre‐François Laterre, Thierry Dugernier, Critical Care	2010	363
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock Fabio Silvio Taccone, Pierre‐François Laterre, Herbert Spapen, Critical Care	2010	198
Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Martin Buysschaert, Anne-Sophie Dramais, Pierre Wallemacq, Diabetes Care	2000	191
Correlation of Mycophenolic Acid Pharmacokinetic Parameters with Side Effects in Kidney Transplant Patients Treated with Mycophenolate Mofetil Michel Mourad, Jacques Malaise, Djamila Chaïb Eddour, Clinical Chemistry	2001	190
Early Signs And Risk Factors For The Increased Incidence Of Epstein-Barr Virus-Related Posttransplant Lymphoproliferative Diseases In Pediatric Liver Transplant Recipients Treated With Tacrolimus Étienne Sokal, Henedina Antunes, Claire Beguin, Transplantation	1997	185
CYP3A5 and ABCB1 Polymorphisms and Tacrolimus Pharmacokinetics in Renal Transplant Candidates: Guidelines from an Experimental Study Vincent Haufroid, Pierre Wallemacq, V. VanKerckhove, American Journal of Transplantation	2006	181
Effect of a New Functional<i>CYP3A4</i>Polymorphism on Calcineurin Inhibitors‘ Dose Requirements and Trough Blood Levels in Stable Renal Transplant Patients Laure Elens, Ron HN van Schaik, Nadtha Panin, Pharmacogenomics	2011	151
Therapeutic Drug Monitoring of Everolimus Maria Shipkova, Dennis A. Hesselink, David W. Holt, Therapeutic Drug Monitoring Pharmaceutical ScienceImmunologyPharmacotherapyImmunotherapyTranslational Pharmacology	2016	131

Page 1